Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1775-97-9

Post Buying Request

1775-97-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1775-97-9 Usage

Description

4',6'-DIMETHOXY-2'-HYDROXYCHALCONE is a natural chalcone derived from various plant sources, characterized by its unique chemical structure featuring methoxy and hydroxy groups at specific positions. It possesses a wide range of biological activities and potential applications in the pharmaceutical and cosmetic industries due to its ability to interact with various biological targets.

Uses

Used in Pharmaceutical Applications:
4',6'-DIMETHOXY-2'-HYDROXYCHALCONE is used as a bioactive compound for its potential anticancer properties. It has demonstrated the ability to induce apoptosis in cancer cells, inhibit cell growth, and modulate various signaling pathways involved in cancer progression. Its unique chemical structure allows it to target and interact with specific proteins and enzymes, making it a promising candidate for the development of novel cancer therapeutics.
Used in Cosmetic Applications:
4',6'-DIMETHOXY-2'-HYDROXYCHALCONE is used as an active ingredient in the cosmetic industry for its potential skin-whitening and anti-aging effects. The compound's ability to modulate cellular signaling pathways and interact with proteins involved in skin pigmentation and aging processes makes it a valuable addition to skincare products.
Used in Antifungal Applications:
4',6'-DIMETHOXY-2'-HYDROXYCHALCONE is used as a potential candidate for the development of novel antifungal phytotherapeutic products. Its ability to target and inhibit the growth of various fungal pathogens makes it a promising compound for the treatment of fungal infections.
Used in Drug Delivery Systems:
To enhance the bioavailability and therapeutic outcomes of 4',6'-DIMETHOXY-2'-HYDROXYCHALCONE, various drug delivery systems have been developed. These systems, including organic and metallic nanoparticles, aim to improve the compound's delivery to target cells, increasing its efficacy and reducing potential side effects.

Check Digit Verification of cas no

The CAS Registry Mumber 1775-97-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,7,7 and 5 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1775-97:
(6*1)+(5*7)+(4*7)+(3*5)+(2*9)+(1*7)=109
109 % 10 = 9
So 1775-97-9 is a valid CAS Registry Number.

1775-97-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 4',6'-DIMETHOXY-2'-HYDROXYCHALCONE

1.2 Other means of identification

Product number -
Other names CARDAMONIN-4'-METHYL ETHER

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1775-97-9 SDS

1775-97-9Relevant articles and documents

Synthesis and acetylcholinesterase inhibitory activity of Mannich base derivatives flavokawain B

Liu, Hao-Ran,Huang, Xue-Qin,Lou, Ding-Hui,Liu, Xian-Jun,Liu, Wu-Kun,Wang, Qiu-An

, p. 4749 - 4753 (2014)

A novel series of flavokawain B derivatives, chalcone Mannich bases (4-10) were designed, synthesized, characterized, and evaluated for the inhibition activity against acetylcholinesterase (AChE). Biological results revealed that four compounds displayed potent activities against AChE with IC50values below 20 μM. Moreover, the most promising compound 8 was 2-fold more active than rivastigmine, a well-known AChE inhibitor. The log P values of 4-10 were around 2 which indicated that they were sufficiently lipophilic to pass blood brain barriers in vivo. Enzyme kinetic study suggested that the inhibition mechanism of compound 8 was a mixed-type inhibition. Meanwhile, the molecular docking showed that this compound can both bind with the catalytic site and the periphery of AChE.

An efficient synthesis of chrysin

Liu, Man,Zhang, Ji,Yang, Jian,Yang, Bo,Cui, Wei

, p. 134 - 136 (2014)

Two routes for the synthesis of the flavones chrysin are described. In the first 1,3,5-trimethoxybenzene was converted to 2-hydroxy-4,6- dimethoxyacetophenone and then by condensation with benzaldehyde to 2′-hydroxy-4′,6′-dimethoxychalcone. The latter was cyclised with iodine and demethylated with pyridine hydrochloride to form chrysin in 53% overall yield. In the second route, 1,3,5-trimethoxybenzene was acylated with cinnamic acid to form the chalcone which was then converted to chrysin in 30.7% overall yield.

Melanogenic inhibition and toxicity assessment of flavokawain A and B on B16/F10 melanoma cells and zebrafish (Danio rerio)

Abdul Bahari, Mohammad Nazri,Ahmad, Syahida,Akhtar, Muhammad Nadeem,Balia Yusof, Zetty Norhana,Latif, Naimah,Md Razip, Nurliyana Najwa,Mohd Ma’in, Farah Idayu,Sakeh, Nurshafika Mohd

, (2020)

Excessive production of melanin implicates hyperpigmentation disorders. Flavokawain A (FLA) and flavokawain B (FLB) have been reported with anti-melanogenic activity, but their melanogenic inhibition and toxicity effects on the vertebrate model of zebrafish are still unknown. In the present study, cytotoxic as well as melanogenic effects of FLA and FLB on cellular melanin content and tyrosinase activity were evaluated in α-MSH-induced B16/F10 cells. Master regulator of microphthalmia-associated transcription factor (Mitf) and the other downstream melanogenic-related genes were verified via quantitative real time PCR (qPCR). Toxicity assessment and melanogenesis inhibition on zebrafish model was further observed. FLA and FLB significantly reduced the specific cellular melanin content by 4.3-fold and 9.6-fold decrement, respectively in α-MSH-induced B16/F10 cells. Concomitantly, FLA significantly reduced the specific cellular tyrosinase activity by 7-fold whilst FLB by 9-fold. The decrement of melanin production and tyrosinase activity were correlated with the mRNA suppression of Mitf which in turn down-regulate Tyr, Trp-1 and Trp-2. FLA and FLB exhibited non-toxic effects on the zebrafish model at 25 and 6.25 μM, respectively. Further experiments on the zebrafish model demonstrated successful phenotype-based depigmenting activity of FLA and FLB under induced melanogenesis. To sum up, our findings provide an important first key step for both of the chalcone derivatives to be further studied and developed as potent depigmenting agents.

Chalcone derivative and application thereof

-

Paragraph 0014-0016, (2021/07/01)

The invention discloses a chalcone derivative and application thereof. The chemical structure of the chalcone derivative is shown as a formula (a) or a formula (b). The chalcone derivative can effectively inhibit proliferation of tumor cells, and a novel lead compound is provided for development of antitumor drugs.

Biotransformation of 5,7-Methoxyflavones by Selected Entomopathogenic Filamentous Fungi

?u?ny, Mateusz,Tronina, Tomasz,Koz?owska, Ewa,Kostrzewa-Sus?ow, Edyta,Janeczko, Tomasz

, p. 3879 - 3886 (2021/05/04)

5,7-Dimethoxyflavone, a chrysin derivative, occurs in many plants and shows very low toxicity, even at high doses. On the basis of this phenomenon, we biotransformed a series of methoxy-derivatives of chrysin, apigenin, and tricetin obtained by chemical synthesis. We used entomopathogenic fungal strains with the confirmed ability of simultaneous hydroxylation/demethylation and glycosylation of flavonoid compounds. Both the amount and the place of attachment of the methoxy group influenced the biotransformation rate and the product's amount nascent. Based on product and semi-product structures, it can be concluded that they are the result of cascading transformations. Only in the case of 5,7,3′,4′,5′-pentamethoxyflavone, the strains were able to attach a sugar molecule in place of the methoxy substituent to give 3′-O-β-d-(4″-O-methylglucopyranosyl)-5,7,4′,5′-tetramethoxyflavone. However, we observed the tested strains' ability to selectively demethylate/hydroxylate the carbon C-3′ and C-4′ of ring B of the substrates used. The structures of four hydroxyl-derivatives were determined: 4′-hydroxy-5,7-dimethoxyflavone, 3′-hydroxy-5,7-dimethoxyflavone, 3′-hydroxy-5,7,4′,5′-tetramethoxyflavone, and 5,7-dimethoxy-3′,4′-dihydroxyflavone (5,7-dimethoxy-luteolin).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1775-97-9